Completed
A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults
NCT03758612
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
- Locations
-
- Worldwide Clinical Trials (WCT) San Antonio, Texas, United States